Q2 2026 saw net income double and adjusted EBITDA rise 45% year-over-year, driven by strong surfactant and polymer performance, higher sales volumes, and margin recovery. Project Catalyst restructuring and customer pre-buys also impacted results.Original document: Stepan Company [SCL] SEC 8-K Curre…
Q2 2026 saw net income double and adjusted EBITDA rise 45% year-over-year, driven by strong surfactant and polymer performance, higher sales volumes, and margin recovery. Project Catalyst restructuring and customer pre-buys also impacted results.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.